A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 31 Dec 2017
At a glance
- Drugs Afatinib; Nintedanib
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 09 Dec 2008 New trial record.